Eskay Pharmaceuticals & Surgicals

Ryzodeg FlexPen is a prefilled, disposable insulin pen containing a combination of insulin degludec (70%) and insulin aspart (30%). It is used to treat diabetes mellitus in adults.
Key Features
1. Long-acting and rapid-acting insulin: Provides a basal insulin supply (insulin degludec) and a peak insulin supply (insulin aspart).2. Once-daily dosing: Convenient dosing schedule, with the option to administer the dose at the same time every day.3. Prefilled, disposable pen: Easy to use and administer insulin doses, with a simple and discreet design.
Benefits
1. Improved glycemic control: Helps regulate blood sugar levels and reduce the risk of hypoglycemia.2. Convenient dosing: Once-daily dosing schedule and prefilled pen make it easy to manage diabetes.3. Reduced risk of hypoglycemia: Insulin degludec has a low risk of hypoglycemia due to its flat and stable action profile.4. Flexibility: Dose can be adjusted in 1-unit increments, allowing for precise dosing.
Dosage
1. Adults: The recommended starting dose is 10-20 units once daily, with the option to adjust the dose based on individual needs.
Side Effects
Common side effects are generally mild and may include:
1. Hypoglycemia2. Injection site reactions3. Allergic reactions4. Weight gain5. Nausea6. Diarrhea
Precautions
1. Consult a healthcare professional before using Ryzodeg FlexPen, especially if you have a history of kidney or liver disease, or are taking medications.2. Monitor blood sugar levels regularly while taking this medication.3. Rotate injection sites to reduce the risk of injection site reactions.4. Do not mix with other insulins.
Storage and Handling
1. Store Ryzodeg FlexPen at room temperature (15°C to 30°C / 59°F to 86°F).2. Protect from light and moisture.3. Use within the expiration date printed on the packaging.4. Dispose of the pen safely after use.

NovoMix 30 FlexPen is a prefilled insulin pen containing Biphasic Insulin Aspart, a mixture of fast-acting and intermediate-acting insulin. Here's a detailed description:
Key Ingredients
1. Biphasic Insulin Aspart: A mixture of 30% fast-acting insulin aspart and 70% intermediate-acting insulin aspart.
Benefits
1. Improves glycemic control: NovoMix 30 FlexPen helps regulate blood sugar levels, reducing the risk of complications associated with diabetes.2. Convenient and easy to use: The FlexPen is a prefilled, disposable pen that makes it easy to administer insulin.3. Reduced risk of hypoglycemia: The biphasic formulation helps reduce the risk of hypoglycemia (low blood sugar) compared to shorter-acting insulins.
Dosage
1. Adults and children: Take as directed by a healthcare professional, typically administered subcutaneously within 10 minutes of starting a meal.
Side Effects
Common side effects are generally mild and may include:
1. Injection site reactions2. Hypoglycemia3. Weight gain4. Edema5. Allergic reactions
Precautions
1. Consult a healthcare professional before taking NovoMix 30 FlexPen, especially if you have a history of kidney or liver disease, or are taking medications.2. Pregnancy and breastfeeding: Use only under medical supervision.3. Monitor blood sugar levels regularly while taking this medication.4. Rotate injection sites to minimize the risk of injection site reactions.
Storage and Handling
1. Store NovoMix 30 FlexPen in the refrigerator at 2°C to 8°C (36°F to 46°F).2. Do not freeze.3. Protect from light.4. Use within 4 weeks of opening.

Ryzodeg Penfill is a prefilled insulin pen containing a combination of insulin degludec (70%) and insulin aspart (30%). It is used to treat diabetes mellitus in adults.
Key Features
1. Long-acting and rapid-acting insulin: Provides a basal insulin supply (insulin degludec) and a peak insulin supply (insulin aspart).2. Once-daily dosing: Convenient dosing schedule, with the option to administer the dose at the same time every day.3. Prefilled pen: Easy to use and administer insulin doses.
Benefits
1. Improved glycemic control: Helps regulate blood sugar levels and reduce the risk of hypoglycemia.2. Convenient dosing: Once-daily dosing schedule and prefilled pen make it easy to manage diabetes.3. Reduced risk of hypoglycemia: Insulin degludec has a low risk of hypoglycemia due to its flat and stable action profile.
Dosage
1. Adults: The recommended starting dose is 10-20 units once daily, with the option to adjust the dose based on individual needs.
Side Effects
Common side effects are generally mild and may include:
1. Hypoglycemia2. Injection site reactions3. Allergic reactions4. Weight gain5. Nausea6. Diarrhea
Precautions
1. Consult a healthcare professional before using Ryzodeg Penfill, especially if you have a history of kidney or liver disease, or are taking medications.2. Monitor blood sugar levels regularly while taking this medication.3. Rotate injection sites to reduce the risk of injection site reactions.4. Do not mix with other insulins.
Storage and Handling
1. Store Ryzodeg Penfill at room temperature (15°C to 30°C / 59°F to 86°F).2. Protect from light and moisture.3. Use within the expiration date printed on the packaging.